Cullinan Therapeutics (CGEM) Stock Insights

CGEM price $15.56 +0.72 +4.85%

Ticker
CGEM
Price
$15.56
Change
+0.72 +4.85%
Market cap ?
$956.29M
P/E ?
-4.26
Dividend yield ?
0.00%
Beta ?
-0.01
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
68
Value
57
Quality
48
Growth
100

Stocklytics score rationale: value 57, quality 48, growth 100.

Financials

20182019202020212022202320242025
000189430000000

Cullinan Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops therapies for autoimmune diseases and cancer in the United States. It engages in the development of CLN-978, a CD19xCD3 bispecific T cell engager for autoimmune diseases in Phase 1 clinical trials; Velinotamig, a BCMAxCD3 bispecific T cell in Phase 1 clinical trials in patients with autoimmune diseases; and CLN-049, a FLT3xCD3…

Fair value

CGEM fair value $93.04. Price $15.56. Price is 83% below fair value.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Model uncertainty high for this stock

Compare CGEM

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-05—-0.84—2.00M
2026-08-06-0.81-0.80—3.67M
2026-05-07-0.75-0.84—3.67M
2026-03-10-0.77-0.80—5.00M
2025-11-06-0.77-0.95—5.56M
2025-08-07-1.07-0.83——
2025-05-08-0.74-0.78——
2025-02-27-0.73-0.75——
2024-11-07-0.69-0.78——
2024-08-08-0.75-0.73——
2024-05-15-0.86-0.90——
2024-03-14-0.54-0.96——
2023-11-08-0.91-0.91——
2023-08-10-0.82-0.99——
2023-05-11-1.42-0.84——
2023-03-09-0.59-0.65——
2022-11-14-0.54-0.97——
2022-08-103.775.42—275.00M
2022-05-16-0.27-0.61——
2022-03-17-0.74-0.4737.85M—
2021-11-09-0.40-0.42——
2021-08-10-0.36-0.42——
2021-05-14-0.000.0718.94M34.50M
2021-03-30-2.86-0.38——
2021-01-06-0.26———
2020-06-30-0.45———
2020-03-31-0.26———
2019-12-31-0.24———
2019-09-30-6.82———
2019-06-30-5.94———
2019-03-31-5.94———

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-09-08Michaelson JenniferBuy4.00K$4.3017.20K
2026-09-08Michaelson JenniferSell8.00K$21.57172.56K
2026-09-08Michaelson JenniferSell4.00K$4.3017.20K
2026-08-13Michaelson JenniferBuy30.00K$4.30129.00K
2026-08-13Michaelson JenniferSell30.00K$20.26607.80K
2026-08-13Michaelson JenniferSell30.00K$4.30129.00K
2026-07-06Michaelson JenniferBuy4.00K$4.3017.20K
2026-07-06Michaelson JenniferSell8.00K$17.82142.56K
2026-07-06Michaelson JenniferSell4.00K$4.3017.20K
2026-06-30SUMER JACQUELYN LBuy2.47K$8.6021.24K
2026-06-30Fenton Mary KayBuy1.54K$8.6013.25K
2026-06-16Rosenberg AnthonyBuy25.32K$13.55343.07K
2026-06-16Meek David D.Buy25.32K$13.55343.07K
2026-06-16Webster Stephen WBuy25.32K$13.55343.07K
2026-06-16Allen Andrew RBuy21.78K$13.55295.13K
2026-06-16Thistle MaryBuy25.32K$13.55343.07K
2026-06-16Doyle MittieBuy21.78K$13.55295.13K
2026-05-05Michaelson JenniferBuy4.00K$4.3017.20K
2026-05-05Michaelson JenniferSell7.80K$14.60113.88K
2026-05-05Michaelson JenniferSell200$15.583.12K
2026-05-05Michaelson JenniferSell4.00K$4.3017.20K
2026-03-05Michaelson JenniferBuy4.00K$4.3017.20K
2026-03-05Michaelson JenniferSell8.00K$15.68125.44K
2026-03-05Michaelson JenniferSell4.00K$4.3017.20K
2026-02-25Michaelson JenniferSell1.78K$14.1425.17K
2026-02-24Michaelson JenniferSell3.60K$14.4752.11K
2026-02-24AHMED NADIMSell13.52K$14.47195.56K
2026-02-24Jones Jeffrey AlanSell4.58K$14.4766.30K
2026-02-24SUMER JACQUELYN LSell3.60K$14.4752.11K
2026-02-23Michaelson JenniferSell1.75K$13.9924.51K
2026-02-20Jones Jeffrey AlanSell4.98K$13.6267.85K
2026-02-20Michaelson JenniferBuy8.00K$4.3034.40K
2026-02-20Michaelson JenniferSell3.74K$13.6250.97K
2026-02-20Michaelson JenniferSell8.00K$14.30114.40K
2026-02-20Michaelson JenniferSell8.00K$4.3034.40K
2026-02-20SUMER JACQUELYN LSell3.74K$13.6250.97K
2026-02-20AHMED NADIMSell16.38K$13.62223.11K
2026-02-20Fenton Mary KaySell4.40K$13.6259.90K
2026-02-18SUMER JACQUELYN LBuy230.00K$12.442.86M
2026-02-18Jones Jeffrey AlanBuy300.00K$12.443.73M
2026-02-18AHMED NADIMBuy828.00K$12.4410.30M
2026-02-18Savill CorrineBuy175.00K$12.442.18M
2026-02-18Fenton Mary KayBuy137.50K$12.441.71M
2026-02-18Fenton Mary KayBuy68.75K——
2026-02-18Michaelson JenniferBuy57.50K——
2026-02-18Michaelson JenniferBuy115.00K$12.441.43M
2026-02-12Michaelson JenniferSell416$12.035.00K
2026-01-22Michaelson JenniferSell4.00K$12.3049.20K
2025-12-31Fenton Mary KayBuy27$6.49175
2025-12-23AHMED NADIMSell9.92K$10.0199.32K
2025-12-19Michaelson JenniferSell1.34K$10.0113.46K
2025-12-18SUMER JACQUELYN LSell3.48K$9.6733.65K
2025-12-18Jones Jeffrey AlanSell4.63K$9.6744.79K
2025-12-18Michaelson JenniferSell2.90K$9.6728.02K
2025-12-15Michaelson JenniferSell995$11.9011.84K
2025-12-12Michaelson JenniferSell2.15K$12.3826.59K
2025-11-24Michaelson JenniferSell4.00K$12.3049.20K
2025-10-28Lynx1 Capital Management LPBuy165.67K$8.401.39M
2025-10-17Lynx1 Capital Management LPBuy32.22K$7.84252.57K
2025-10-16Lynx1 Capital Management LPBuy150.00K$8.861.33M
2025-10-15Lynx1 Capital Management LPBuy51.50K$7.94409.05K
2025-10-14Lynx1 Capital Management LPBuy15.03K$7.59114.05K
2025-10-10Lynx1 Capital Management LPBuy277.30K$7.362.04M
2025-10-09Lynx1 Capital Management LPBuy626.04K$6.704.19M
2025-10-08Lynx1 Capital Management LPBuy556.30K$6.463.59M
2025-10-08Lynx1 Capital Management LPOther0——
2025-08-07Doyle MittieBuy79.46K$7.03558.58K
2025-08-07Allen Andrew RBuy79.46K$7.03558.58K
2025-08-07Allen Andrew ROther0——
2025-08-07Doyle MittieOther0——
2025-06-12Ryan David P.Buy38.51K$8.95344.69K
2025-06-12Rosenberg AnthonyBuy38.51K$8.95344.69K
2025-06-12Webster Stephen WBuy38.51K$8.95344.69K
2025-06-12Meek David D.Buy38.51K$8.95344.69K
2025-06-12Martin Anne-MarieBuy38.51K$8.95344.69K
2025-02-25Jones Jeffrey AlanSell4.89K$8.5341.75K
2025-02-25AHMED NADIMSell12.53K$8.53106.87K
2025-02-25Michaelson JenniferSell3.76K$8.5332.04K
2025-02-25SUMER JACQUELYN LSell3.76K$8.5332.04K
2025-02-19Michaelson JenniferBuy50.00K——
2025-02-19Michaelson JenniferBuy100.00K$9.43943.00K
2025-02-19Savill CorrineBuy37.50K——
2025-02-19Savill CorrineBuy75.00K$9.43707.25K
2025-02-19SUMER JACQUELYN LBuy50.00K——
2025-02-19SUMER JACQUELYN LBuy100.00K$9.43943.00K
2025-02-19AHMED NADIMBuy180.00K——
2025-02-19AHMED NADIMBuy360.00K$9.433.39M
2025-02-19Jones Jeffrey AlanBuy65.00K——
2025-02-19Jones Jeffrey AlanBuy130.00K$9.431.23M
2025-02-19Fenton Mary KayBuy120.00K$9.431.13M
2025-02-19Fenton Mary KayBuy60.00K——
2025-01-06Michaelson JenniferSell4.00K$12.5150.04K
2024-12-24AHMED NADIMSell8.40K$11.8799.71K
2024-12-18Michaelson JenniferSell4.69K$11.4153.55K
2024-12-18Jones Jeffrey AlanSell4.63K$11.4152.85K
2024-12-18SUMER JACQUELYN LSell3.48K$11.4139.73K
2024-12-12Michaelson JenniferSell3.49K$12.5243.68K
2024-11-05Michaelson JenniferSell8.00K$15.64125.12K
2024-09-05Michaelson JenniferSell8.00K$18.09144.72K
2024-08-08Thistle MaryOther0——

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 193, holders +16 vs prior quarter. Ownership 121.82%.

HolderSharesChangeChange %Value
MPM BIOIMPACT LLC9.73M2.08M+27.24%177.21M
LYNX1 CAPITAL MANAGEMENT LP8.96M00.00%163.23M
BVF INC/IL5.75M00.00%104.72M
BLACKROCK, INC.5.23M782.80K+17.59%95.29M
PRICE T ROWE ASSOCIATES INC /MD/3.83M1.80M+88.50%69.67M
STATE STREET CORP3.67M1.12M+44.20%66.81M
KYNAM CAPITAL MANAGEMENT, LP3.11M00.00%56.71M
VANGUARD CAPITAL MANAGEMENT LLC2.61M131.03K+5.28%47.60M
RTW INVESTMENTS, LP2.36M658.39K+38.59%43.05M
SIREN, L.L.C.1.89M700.00K+58.66%34.48M
GEODE CAPITAL MANAGEMENT, LLC1.55M179.04K+13.09%28.18M
BLUE OWL CAPITAL HOLDINGS LP1.54M-370.00K-19.37%28.04M
VENROCK ADVISER, LLC1.38M00.00%25.13M
BOOTHBAY FUND MANAGEMENT, LLC1.08M-30.19K-2.71%19.71M
DIMENSIONAL FUND ADVISORS LP1.05M140.67K+15.53%19.06M
GOLDMAN SACHS GROUP INC1.00M546.15K+119.91%18.24M
AFFINITY ASSET ADVISORS, LLC875.76K94.50K+12.10%15.95M
VANGUARD PORTFOLIO MANAGEMENT LLC738.74K186.19K+33.70%13.45M
BOONE CAPITAL MANAGEMENT LLC704.44K704.44KNew12.83M
ELMIND CAPITAL, LP690.00K160.00K+30.19%12.56M
MORGAN STANLEY629.03K39.55K+6.71%11.45M
TWIN FOCUS CAPITAL PARTNERS, LLC595.49K00.00%10.84M
AQR CAPITAL MANAGEMENT LLC581.34K220.46K+61.09%10.59M
NORTHERN TRUST CORP571.08K121.82K+27.12%10.40M
BANK OF AMERICA CORP /DE/510.32K-6.40K-1.24%9.29M

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Cullinan Therapeutics (CGEM) Stock Insights

CGEM$15.56+0.72 +4.85%

$956.29M

Market Cap

-4.26

P/E

—

Forward P/E

68

Score

Price History